BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences Reports Second Quarter 2026 Financial Results

Integra LifeSciences (IART)Integra LifeSciencesEarnings

PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2026. Second Quarter 2026 Highlights Second quarter revenues of $418.8

Related news

IARTIntegra LifeSciences2026-07-16 12:00 EST

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

TMCITreace Medical Concepts2026-08-07 11:05 EST

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

CVRXCVRx2026-08-06 20:05 EST

CVRx Reports Second Quarter 2026 Financial and Operating Results

APYXApyx Medical2026-08-06 20:05 EST

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

AORTArtivion2026-08-06 20:05 EST

Artivion Reports Second Quarter 2026 Financial Results

IRTCiRhythm2026-08-06 20:05 EST

iRhythm Holdings Announces Second Quarter 2026 Financial Results

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

HYPRHyperfine2026-08-06 20:05 EST

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

DNLIDenali Therapeutics2026-08-06 20:01 EST

Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

SENSSenseonics2026-08-06 20:01 EST

Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Integra LifeSciences Reports Second Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-07-16 12:00 EST

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

IARTIntegra LifeSciences2026-07-02 12:30 EST

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

IARTIntegra LifeSciences2026-06-23 12:00 EST

Integra LifeSciences Announces Key Executive Appointments

IARTIntegra LifeSciences2026-06-15 12:30 EST

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Stock data

Close
17.10 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States